Progression of conventional hepatic cell culture models to bioengineered HepG2 cells for evaluation of herbal bioactivities
- 317 Downloads
Cancer cell lines of human tissue origin have been extensively used to investigate antiproliferative activity and toxicity of herbal extracts, isolated compounds, and anticancer drugs. These cell lines are genetically and/or epigenetically well characterized to determine the altered expression of proteins within given cellular pathways and critical genes in cancer. Human derived hepatoma (HepG2) cell line has been extensively exploited to examine cytoprotective, antioxidative, hepatoprotective, anti-hepatoma, hypocholesterolemic, anti-steatosis, bioenergetic homeostatic and anti-insulin resistant properties. Moreover, mechanism of action of various botanicals and bioactive constituents has been reported using these cells. HepG2 cells have significant differences as compared to primary hepatocytes with respect to expression of cytochrome P450 enzymes and xenobiotic receptors in conventional in vitro culture conditions. Therefore, strategies have been employed to overcome limitations of two dimensional (2D) in vitro HepG2 cell culture in order to recognize functional biomarkers more accurately and to boost its predictive value in clinical research. In consequence, three dimensional (3D) human hepatoma cell culture models are being developed as a resource to achieve these goals of simulating the in vivo tumor microenvironment. It is assumed that bioengineered 3D hepatoma cell culture models can provide significant assistance in scrutinizing the molecular response of herbal natural products to recognize novel prognostic targets and crucial biomarkers in treatment strategies for cancer patients in near future.
KeywordsBioengineering Biomarkers HepG2 Herbal bioactivity In vitro model
The first author duly acknowledges the University Grants Commission (UGC), New Delhi for providing Scholarship under the Scheme MANF (vide Grant No. 201213-MANF-2012-13-SIK-PUN-16650).
- ATCC. https://www.atcc.org/products/all/HB-8065.aspx#characteristics. Accessed 24 Nov 2017
- Bhise NS, Manoharan V, Massa S, Tamayol A, Ghaderi M, Miscuglio M, Lang Q, Shrike Zhang Y, Shin SR, Calzone G, Annabi N, Shupe TD, Bishop CE, Atala A, Dokmeci MR, Khademhosseini A (2016) A liver-on-a-chip platform with bioprinted hepatic spheroids. Biofabrication 8:014101. https://doi.org/10.1088/1758-5090/8/1/014101 CrossRefPubMedGoogle Scholar
- Cao Z, Lin W, Huang Z, Chen X, Zhao J, Zheng L, Ye H, Liu Z, Liao L, Du J (2013) Ethyl acetate extraction from a Chinese herbal formula, Jiedu Xiaozheng Yin, inhibits the proliferation of hepatocellular carcinoma cells via induction of G0/G1 phase arrest in vivo and in vitro. Int J Oncol 42:202–210CrossRefPubMedGoogle Scholar
- Chu Q, Zhao Y, Shi X, Han W, Zhang Y, Zheng X, Zhu J (2017) In vivo-like 3-D model for sodium nitrite- and acrylamide-induced hepatotoxicity tests utilizing HepG2 cells entrapped in micro-hollow fibres. Sci Rep 7:14837. https://doi.org/10.1038/s41598-017-13147-z CrossRefPubMedPubMedCentralGoogle Scholar
- Feng Q, Gou XJ, Meng SX, Huang C, Zhang YQ, Tang YJ, Wang WJ, Xu L, Peng JH, Hu YY (2013) Qushi Huayu decoction inhibits hepatic lipid accumulation by activating AMP-activated protein kinase in vivo and in vitro. Evid Based Complement Altern Med 2013:184358. https://doi.org/10.1155/2013/184358 Google Scholar
- Ferreira D, Adega F, Chaves R (2013) The importance of cancer cell lines as in vitro models in cancer methylome analysis and anticancer drugs testing. In: César LC, Elena AO (eds) Oncogenomics and cancer proteomics—novel approaches in biomarkers discovery and therapeutic targets in cancer. InTech Publishers, Rijeka, pp 139–166Google Scholar
- Nakamura K, Mizutani R, Sanbe A, Enosawa S, Kasahara M, Nakagawa A, Ejiri Y, Murayama N, Miyamoto Y, Torii T, Kusakawa S, Yamauchi J, Fukuda M, Yamazaki H, Tanoue A (2011) Evaluation of drug toxicity with hepatocytes cultured in a micro-space cell culture system. J Biosci Bioeng 111:78–84CrossRefPubMedGoogle Scholar
- Ramachandran S, Menon DB (2016) Synergistic effect of spices in a decoction regulates the energy metabolism in liver cancer cells. Int J Phytomed 8:29–36Google Scholar
- Samarakoon SR, Thabrew I, Galhena PB, Tennekoon KH (2012) Modulation of apoptosis in human hepatocellular carcinoma (HepG2 cells) by a standardized herbal decoction of Nigella sativa seeds, Hemidesmus indicus roots and Smilax glabra rhizomes with anti-hepatocarcinogenic effects. BMC Complement Altern Med 12:25. https://doi.org/10.1186/1472-6882-12-25 CrossRefPubMedPubMedCentralGoogle Scholar
- Yotsumoto H, Yanagita T, Yamamoto K, Ogawa Y, Cha JY, Mori Y (1997) Inhibitory effects of Oren-Gedoku-to and its components on cholesteryl ester synthesis in cultured human hepatocyte HepG2 cells: evidence from the cultured Hep2G cells and in vitro assay of ACAT. Planta Med 63:141–145CrossRefPubMedGoogle Scholar